Condition: Brain Metastases · Radiation Necrosis · Recurrent Tumor · Sponsor: Monteris Medical
Randomized, post-market multi-center study investigating the efficacy of two sets of treatment algorithms in brain metastases (BM) patients at the time of first intervention for radiographic progression after stereotactic radiosurgery (SRS), with or without surgery.
This description comes directly from the study's public registry record.
Christa Seligman · 952-463-7747 · cseligman@monteris.com
Kate Weed · kweed@monteris.com
Always discuss trial participation with your own doctor first.
| UCLA | Los Angeles, California, United States | Recruiting |
| University of Chicago | Chicago, Illinois, United States | Recruiting |
| University of Maryland | Baltimore, Maryland, United States | Recruiting |
| WashU | St Louis, Missouri, United States | Recruiting |
| Duke University Hospital | Durham, North Carolina, United States | Active Not Recruiting |
| Wake Forest Baptist Medical Center | Winston-Salem, North Carolina, United States | Recruiting |
| Cleveland Clinic | Cleveland, Ohio, United States | Recruiting |
| Kettering Health | Kettering, Ohio, United States | Recruiting |
| Medical College of Wisconsin | Milwaukee, Wisconsin, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05124912